Abstract
The human race has been seeking ways to protect themselves in order to prevent the emergence of deadly diseases from centuries. As it is known, the practice of inoculation for the prevention of disease is of considerable antiquity. A vaccination is a substance that is given to a person to boost the immune system. It can be administered through various routes to prevent and to protect the community from contracting an infectious disease. Microorganisms are closely related to vaccination. To get employed in vaccinations, the disease-causing bacteria are either attenuated or heated/chemically treated. The genetic makeup of the microorganisms used in DNA vaccine production is also crucial. Additionally, in order to boost immune response and memory against the disease-causing pathogen, microorganisms are also utilized as vaccine vectors. As part of this chapter, microbes are discussed as they are used for the development of the first generation of vaccines to the current generation of DNA and mRNA vaccines. Also discussed are the subunit and conjugate vaccines made from microorganisms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baicus A (2012) History of polio vaccination. World J Virol 1:108–114
Boylston A (2012) The origins of inoculation. J R Soc Med 105:309–313
Capasso C, Garofalo M, Hirvinen M, Cerullo V (2014) The evolution of adenoviral vectors through genetic and chemical surface modifications. Viruses 6:832–855
Casto DT, Brunell PA (1991) Safe handling of vaccines. Pediatrics 87:108–112
Cate TR, Couch RB, Kasel JA, Six HR (1977) Clinical trials of monovalent influenza a/New Jersey/76 virus vaccines in adults: reactogenicity, antibody response, and antibody persistence. J Infect Dis 136(Suppl):S450–S455
Centers for Disease Control and Prevention (2012) National vaccine program office vaccine fact sheets; [cited 2012 Mar 7]. http://www.cdc.gov/vaccines/pubs/vis/vis-facts.htm#basic
Clem AS (2011) Fundamentals of vaccine immunology. J Glob Infect Dis 3:73–78
Cohen S (2020) The fastest vaccine in history. UCLA Health; [cited 2022 Nov 22]. https://connect.uclahealth.org/2020/12/10/the-fastest-vaccine-in-history/
Dubensky TW, Skoble J, Lauer P, Brockstedt DG (2012) Killed but metabolically active vaccines. Curr Opin Biotechnol 23:917–923
European Medicines Agency (2022) Ich guideline Q5A(R2) on viral safety evaluation of biotechnology products derived from cell lines human or animal origin—scientific guideline European Medicines Agency; [cited 2022 Nov 7]. https://www.ema.europa.eu/en/ich-guideline-q5ar2-viral-safety-evaluation-biotechnology-products-derived-cell-lines-human-animal
Galen J, Buskirk A, Tennant S, Pasetti M (2016) Live attenuated human salmonella vaccine candidates: tracking the pathogen in natural infection and stimulation of host immunity. EcoSal Plus 7:7
Germanier R, Füer E (1975) Isolation and characterization of gal E mutant ty 21a of salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 131:553–558
Giubilini A (2020) The ethics of vaccination. Saint Philip Street Press, p 138
Gomez PL, Robinson JM, Rogalewicz JA (2013) Vaccine manufacturing. Vaccines, pp 44–57
Holmgren J, Svennerholm AM, Jertborn M, Clemens J, Sack DA, Salenstedt R et al (1992) An oral B subunit: whole cell vaccine against cholera. Vaccine 10:911–914
Karanja JK, Kiboi NG (2016) Current milestones towards development of a fully deployable anti-malaria vaccine-future hope for malaria-free world: a review. J Vaccine 7:7
Khan YH, Saifullah A, Mallhi TH (2022) Bacterial vaccines. In: Rezaei N (ed) Encyclopedia of infection and immunity. Oxford, Elsevier, Amsterdam, pp 530–544
Kumar S, Basu M, Ghosh P, Ansari A, Ghosh MK (2022) COVID-19: clinical status of vaccine development to date. Br J Clin Pharmacol 89:114. https://doi.org/10.1111/bcp.15552
Leitner WW, Ying H, Restifo NP (1999) DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 18:765–777
Luca S, Mihaescu T (2013) History of BCG vaccine. Maedica (Bucur) 8:53–58
Mehand MS, Al-Shorbaji F, Millett P, Murgue B (2018) The WHO R&D blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antivir Res 159:63–67
Miller G (2018) The adoption of inoculation for smallpox in England and France. The adoption of inoculation for smallpox in England and France. University of Pennsylvania Press, Philadelphia, PA
Minor PD (2012) The polio-eradication programme and issues of the end game. J Gen Virol 93:457–474
Padda IS, Parmar M (2022) COVID (SARS-COV-2) vaccine. In: StatPearls. StatPearls Publishing, Treasure Island (FL); [cited 2022 Nov 22]. http://www.ncbi.nlm.nih.gov/books/NBK567793/
Pasteur L (1881) De l’atténuation des virus et de leur retour à la virulence. Gauthier-Villars, p 7
Pennington SH, Thompson AL, Wright AKA, Ferreira DM, Jambo KC, Wright AD et al (2016) Oral typhoid vaccination with live-attenuated salmonella Typhi strain Ty21a generates Ty21a-responsive and heterologous influenza virus-responsive CD4+ and CD8+ T cells at the human intestinal mucosa. J Infect Dis 213:1809–1819
Plotkin S (2014) History of vaccination. Proc Natl Acad Sci U S A 111:12283–12287
Ramezanpour B, Haan I, Osterhaus A, Claassen E (2016) Vector-based genetically modified vaccines: exploiting Jenner’s legacy. Vaccine 34:6436–6448
Rauch S, Jasny E, Schmidt KE, Petsch B (2018) New vaccine technologies to combat outbreak situations. Front Immunol 9:1963
Reckseidler-Zenteno SL, Viteri DF, Moore R, Wong E, Tuanyok A, Woods DE (2010) Characterization of the type III capsular polysaccharide produced by Burkholderia pseudomallei. J Med Microbiol 59:1403–1414
Riedel S (2005) Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent) 18:21–25
Rijkers GT, Weterings N, Obregon-Henao A, Lepolder M, Dutt TS, van Overveld FJ et al (2021) Antigen presentation of mRNA-based and virus-vectored SARS-CoV-2 vaccines. Vaccines (Basel) 9:848
Robinson JM (2016) Vaccine production: main steps and considerations. In: The vaccine book, pp 77–96
Sato Y, Sato H (1999) Development of acellular pertussis vaccines. Biologicals 27:61–69
Schneerson R, Barrera O, Sutton A, Robbins JB (1980) Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med 152:361–376
Siegrist CA, Lambert PH (2016) How vaccines work. In: Bloom BR, Lambert PH (eds) The vaccine book, 2nd edn. Academic Press, London, pp 33–42
Tangy F, Naim HY (2005) Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector. Viral Immunol 18:317–326
Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298:347–350
Weaver SC, Charlier C, Vasilakis N, Lecuit M (2018) Zika, chikungunya, and other emerging vector-borne viral diseases. Annu Rev Med 69:395–408
WHO Global Health Workforce Alliance (2020) GAVI—The global alliance for vaccines and immunizations; [cited 2020 Dec 23]. www.who.int/workforcealliance/members_partners/member_list/gavi/en/
Witebsky E (1967) Immunology: views of the past and visions for the future. Can Med Assoc J 97:1371–1377
World Health Organization (2022a) How are vaccines developed?; [cited 2022 Nov 22]. https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed
World Health Organization (2022b) AstraZeneca ChAdOx1-S/nCoV-19 [recombinant], COVID-19 vaccine; [cited 2022 Nov 22]. https://www.who.int/publications/m/item/chadox1-s-recombinant-covid-19-vaccine
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gupta, V., Kour, I., Singhal, L. (2023). Role of Microbes in Production of Vaccines. In: Sobti, R., Kuhad, R.C., Lal, R., Rishi, P. (eds) Role of Microbes in Sustainable Development. Springer, Singapore. https://doi.org/10.1007/978-981-99-3126-2_26
Download citation
DOI: https://doi.org/10.1007/978-981-99-3126-2_26
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-3125-5
Online ISBN: 978-981-99-3126-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)